Bayer Genuine Aspirin, 325 mg (500 ct.)

by Bayer
Save 13%
$17.30
$14.98

Bayer Aspirin, 325 mg

USE ONLY AS DIRECTED

From the Manufacturer

Genuine Bayer® Aspirin

    • Effective pain relief for over 100 years
    • Genuine Bayer Aspirin provides safe pain relief plus life saving benefits
    • Taking Genuine Bayer Aspirin for pain relief does not interfere with the benefits of taking it for an aspirin regimen
    • Under a doctor's supervision, can help reduce the risk of a recurrent heart attack or ischemic stroke

      The Wonder Drug®

    We are proud to be the #1 Doctor Recommended Brand.*

    Aspirin is not appropriate for everyone, so be sure to talk to your doctor before you begin an aspirin regimen.*Source: ProVoice Survey March 2016 MAT

  • Aspirin reduces production of substances called prostaglandins. By inhibiting prostaglandin production, aspirin can relieve general aches and pains. Prostaglandins are also involved in the early stages of your body's blood clotting mechanism. By inhibiting these prostaglandins, aspirin inhibits the formation of blood clots that might block the arteries supplying the heart muscle or brain, increasing the risk of heart attack or ischemic stroke. Essentially, aspirin helps prevent these potential harmful clots from forming.
  • Genuine Bayer® Aspirin

    Genuine Bayer Aspirin provides pain relief from headaches, backaches, muscle pain, toothaches, menstrual pain and minor arthritis pain—and has for over 100 years.

    It’s also recommended, under a doctor's supervision, to help reduce the risk of a recurrent heart attack or ischemic stroke. No other OTC leading brand of pain reliever can do that.

    Taking Genuine Bayer Aspirin for pain relief does not interfere with the benefits of taking it on a doctor-directed aspirin regimen.

    Aspirin is not appropriate for everyone, so be sure to talk to your doctor before you begin an aspirin regimen.
    † Source: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. The Lancet.2009 May 30;373:1386-1399.